151 Patents
- US124809582025Method for the Characterization of Peptide:mhc Binding Polypeptides
Immatics Biotechnologies GmbH
0 cites - US123516162025Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US123184072025Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122959942025Peptides and Combination of Peptides for Use in Immunotherapy Against Pancreatic Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US122959952025Peptides and Combination of Peptides for Use in Immunotherapy Against Pancreatic Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US122959962025Peptides and Combination of Peptides for Use in Immunotherapy Against Pancreatic Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122972452025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - 0 cites
- US122972542025Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122905302025Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122854432025Peptides Displayed by HLA for Use Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122811462025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122747162025Peptides Displayed by HLA for Use Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122757682025In Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122757752025Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122757762025Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122572692025Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122583822025Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122460392025Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US122470572025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122408772025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122408782025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - 0 cites
- US122264662025Peptides and Combination of Peptides for Use in Immunotherapy Against Breast Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122264672025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US122275562025Immunotherapy with B*08 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - 0 cites
- US122214682025Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122216262025Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122140252025Peptides and Combination of Peptides for Use in Immunotherapy Against Pancreatic Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US122028782025Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US121939972025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121939982025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121939992025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121955062025Immunotherapy with A*01 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US121955072025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121955082025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121955092025Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121955162025Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US121862762025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121862772025Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121802562024Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121802592024Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121718192024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121730432024Peptides and Combination of Peptides for Use in Immunotherapy Against Small Cell Lung Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121680432024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121629172024B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US121569052024CCR8 Peptide and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
Immatics Biotechnologies GmbH
0 cites - US121509792024Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121448522024Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121215722024Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121026702024Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US121039842024Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120972482024Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US120972492024Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120844862024Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US120845222024Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120763792024A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US120763802024Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120763812024Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120704912024Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120714582024Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120644652024Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
Immatics Biotechnologies GmbH
0 cites - US120654712024B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US120594582024Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US120603992024Immunotherapy with A*01 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - 0 cites
- US120604062024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
Immatics Biotechnologies GmbH
0 cites - US120362712024Peptides and Combination of Peptides as Targets or Active Ingredients for Use in Immunotherapy Against AML and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120297852024GINS2 Peptide and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
Immatics Biotechnologies GmbH
0 cites - US120233722024Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
Immatics Biotechnologies GmbH
0 cites - US120180642024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
Immatics Biotechnologies GmbH
0 cites - US120051052024Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US120063492024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
Immatics Biotechnologies GmbH
0 cites - US119997742024Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US119750422024Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
Immatics Biotechnologies GmbH
0 cites - US119750582024Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US119694552024Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
Immatics Biotechnologies GmbH
0 cites - US119650132024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
Immatics Biotechnologies GmbH
0 cites - US119577162024Peptides Displayed by HLA for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - 0 cites
- US119577422024Method for Treating Non-small Lung Cancer with a Population of Activated T Cells
Immatics Biotechnologies GmbH
0 cites - US119511322024Peptides and Combination of Peptides of Non-canonical Origin for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US119511602024Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
Immatics Biotechnologies GmbH
0 cites - US119524092024Amidated Peptides and Their Deamidated Counterparts Displayed by Non-hla-a*02 for Use in Immunotherapy Against Different Types of Cancers Preliminary Class
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US119458502024B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US119381762024Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US119393662024Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US119394002024Immunotherapy Against Several Tumors Including Lung Cancer
Immatics Biotechnologies GmbH
0 cites - US119394012024Immunotherapy Against Several Tumors Including Lung Cancer
Immatics Biotechnologies GmbH
0 cites - US119326782024Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US119186072024Peptides and Combination of Peptides of Non-canonical Origin for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US119127482024Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US119127492024Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US119040032024Amidated Peptides and Their Deamidated Counterparts Displayed by HLA-A*02 for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US119053192024Peptides and Combination of Peptides for Use in Immunotherapy Against Small Cell Lung Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118979342024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118979352024Peptides, Combination of Peptides as Targets and for Use in Immunotherapy Against Gallbladder Cancer and Cholangiocarcinoma and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118979362024Peptides, Combination of Peptides as Targets and for Use in Immunotherapy
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118903332024Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118903342024Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118914272024Amidated Peptides and Their Deamidated Counterparts Displayed by Non-hla-a*02 for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118834622024Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118722702024A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118733292024Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118665172024Immunotherapy Against Several Tumors Including Lung Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118590172024Immunotherapy Against Several Tumors Including Lung Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118502742023Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118396432023Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
Immatics Biotechnologies GmbH
0 cites - US118331932023A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118331942023Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118331952023Amidated Peptides and Their Deamidated Counterparts Displayed by HLA-A*02 for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118264092023Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118264102023Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118144462023Immunotherapy Against Several Tumors Including Lung Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US118012642023Peptides and Combination of Peptides of Non-canonical Origin for Use in Immunotherapy Against Different Types of Cancers
Immatics Biotechnologies GmbH
0 cites - US117938662023Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117865832023Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117865842023Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites - US117796052023Immunotherapy with B*08 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites - US117796062023Peptides and Combination of Peptides of Non-canonical Origin for Use in Immunotherapy Against Different Types of Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117796382023Method of Eliciting a CD8+ Cytotoxic Response in Hepatocellular Carcinoma Patients with a Population of Activated T Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117595072023Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117448822023Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117320212023Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US117024602023Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - 0 cites
- US116791472023Method of Eliciting a CD8+ Cytotoxic Response in Hepatocellular Carcinoma Patients with a Population of Activated T Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116800892023B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116728482023Method of Eliciting a CD8+ Cytotoxic Response in Hepatocellular Carcinoma Patients with a Population of Activated T Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116739172023Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116676852023B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116552802023Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116552812023Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116482922023Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116291772023B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116187742023Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116074462023Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116083702023Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US116033972023Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115977522023Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115769542023Method for Treating Non-small Lung Cancer with a Population of Activated Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115769552023A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115769562023Peptides and Combination of Peptides for Use in Immunotherapy Against Hepatocellular Carcinoma (HCC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115595722023Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115595732023Method of Eliciting a CD8+ Cytotoxic Response in Hepatocellular Carcinoma Patients with a Population of Activated T Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115541642023A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115477502023Peptides and T Cells for Use in Immunotherapeutic Treatment Hepatocellular Carcinoma
IMMATICS BIOTECHNOLOGIES GmbH
0 cites - US115411072023Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites